Targeting metastatic colorectal cancer – present and emerging treatment options
Kristen K Ciombor,1 Jordan Berlin21Division of Medical Oncology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA; 2Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USAAbstract: Metastatic colore...
Main Authors: | Ciombor KK, Berlin J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Online Access: | http://www.dovepress.com/targeting-metastatic-colorectal-cancer-ndash-present-and-emerging-trea-a17520 |
Similar Items
-
First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
by: Giuseppe Tonini, et al.
Published: (2009-04-01) -
Emerging combination therapies for metastatic colorectal cancer – impact of trifluridine/tipiracil
by: Puthiamadathil JM, et al.
Published: (2017-10-01) -
Selecting treatment options in refractory metastatic colorectal cancer
by: Byrne M, et al.
Published: (2019-03-01) -
Molecular Targets for the Treatment of Metastatic Colorectal Cancer
by: Romain Cohen, et al.
Published: (2020-08-01) -
Patient considerations in metastatic colorectal cancer – role of panitumumab
by: Rogers JE
Published: (2017-04-01)